211 related articles for article (PubMed ID: 24927576)
1. Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage.
Gregory MT; Park GY; Johnstone TC; Lee YS; Yang W; Lippard SJ
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9133-8. PubMed ID: 24927576
[TBL] [Abstract][Full Text] [Related]
2. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis.
Kellinger MW; Park GY; Chong J; Lippard SJ; Wang D
J Am Chem Soc; 2013 Sep; 135(35):13054-61. PubMed ID: 23927577
[TBL] [Abstract][Full Text] [Related]
3. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
Park GY; Wilson JJ; Song Y; Lippard SJ
Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11987-92. PubMed ID: 22773807
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
[TBL] [Abstract][Full Text] [Related]
5. Protein interactions with platinum-DNA adducts: from structure to function.
Chaney SG; Campbell SL; Temple B; Bassett E; Wu Y; Faldu M
J Inorg Biochem; 2004 Oct; 98(10):1551-9. PubMed ID: 15458816
[TBL] [Abstract][Full Text] [Related]
6. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
Vaisman A; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2000 Apr; 39(16):4575-80. PubMed ID: 10769112
[TBL] [Abstract][Full Text] [Related]
7. Frameshifts and deletions during in vitro translesion synthesis past Pt-DNA adducts by DNA polymerases beta and eta.
Bassett E; Vaisman A; Tropea KA; McCall CM; Masutani C; Hanaoka F; Chaney SG
DNA Repair (Amst); 2002 Dec; 1(12):1003-16. PubMed ID: 12531010
[TBL] [Abstract][Full Text] [Related]
8. Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.
Riddell IA; Johnstone TC; Park GY; Lippard SJ
Chemistry; 2016 May; 22(22):7574-81. PubMed ID: 27111128
[TBL] [Abstract][Full Text] [Related]
9. The chiral potential of phenanthriplatin and its influence on guanine binding.
Johnstone TC; Lippard SJ
J Am Chem Soc; 2014 Feb; 136(5):2126-34. PubMed ID: 24417436
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
Monroe JD; Hruska HL; Ruggles HK; Williams KM; Smith ME
PLoS One; 2018; 13(3):e0192505. PubMed ID: 29513752
[TBL] [Abstract][Full Text] [Related]
11. Monofunctional platinum(II) compounds and nucleolar stress: is phenanthriplatin unique?
McDevitt CE; Yglesias MV; Mroz AM; Sutton EC; Yang MC; Hendon CH; DeRose VJ
J Biol Inorg Chem; 2019 Sep; 24(6):899-908. PubMed ID: 31494760
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of human DNA polymerase η-mediated chemoresistance to cisplatin.
Zhao Y; Biertümpfel C; Gregory MT; Hua YJ; Hanaoka F; Yang W
Proc Natl Acad Sci U S A; 2012 May; 109(19):7269-74. PubMed ID: 22529383
[TBL] [Abstract][Full Text] [Related]
13. A role for polymerase eta in the cellular tolerance to cisplatin-induced damage.
Albertella MR; Green CM; Lehmann AR; O'Connor MJ
Cancer Res; 2005 Nov; 65(21):9799-806. PubMed ID: 16267001
[TBL] [Abstract][Full Text] [Related]
14. Rationalization of the Superior Anticancer Activity of Phenanthriplatin: An In-Depth Computational Exploration.
Dabbish E; Russo N; Sicilia E
Chemistry; 2020 Jan; 26(1):259-268. PubMed ID: 31614021
[TBL] [Abstract][Full Text] [Related]
15. DNA polymerase eta: A potential pharmacological target for cancer therapy.
Saha P; Mandal T; Talukdar AD; Kumar D; Kumar S; Tripathi PP; Wang QE; Srivastava AK
J Cell Physiol; 2021 Jun; 236(6):4106-4120. PubMed ID: 33184862
[TBL] [Abstract][Full Text] [Related]
16. Specificity of platinum-DNA adduct repair.
Chaney SG; Vaisman A
J Inorg Biochem; 1999 Oct; 77(1-2):71-81. PubMed ID: 10626357
[TBL] [Abstract][Full Text] [Related]
17. Translesion synthesis past platinum DNA adducts by human DNA polymerase mu.
Havener JM; Nick McElhinny SA; Bassett E; Gauger M; Ramsden DA; Chaney SG
Biochemistry; 2003 Feb; 42(6):1777-88. PubMed ID: 12578393
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
[TBL] [Abstract][Full Text] [Related]
19. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
Bassett E; King NM; Bryant MF; Hector S; Pendyala L; Chaney SG; Cordeiro-Stone M
Cancer Res; 2004 Sep; 64(18):6469-75. PubMed ID: 15374956
[TBL] [Abstract][Full Text] [Related]
20. Processing and Bypass of a Site-Specific DNA Adduct of the Cytotoxic Platinum-Acridinylthiourea Conjugate by Polymerases Involved in DNA Repair: Biochemical and Thermodynamic Aspects.
Hreusova M; Brabec V; Novakova O
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
